Voyager Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VYGR for the last quarter is 29.58 M USD, and it's 51.56% higher compared to the previous quarter. The net income of Q2 24 is -10.14 M USD.